Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ergobilt (ERGB) - Ergonomic Chairs -- Ignore unavailable to you. Want to Upgrade?

To: Anaxagoras who wrote (752)	3/20/1998 11:15:00 AM
From: Dr. Seuss	Read Replies (1) \| Respond to of 900

Anaxagoras, All it would take is a payment from the other side. That's what moves scamsters like Scott. dr.seuss.com

To: Anaxagoras who wrote (752)	3/20/1998 11:50:00 AM
From: Scott D. Hakala	Read Replies (1) \| Respond to of 900

Anaxagoras, Given the information I had, I wasn't wrong. The Company is growing and profitable. It is still growing and profitable. That being said: I did not expect the revision in the third quarter or the charges associated with the CTTS acquisition, the Foniks Writer developments, the Cheetah acquisition and the legal fees. Had I expected the magnitude of the expenses and the accounting charges, I would not have bought at $12 and $13 in the Fall of 1997, but I would still buy now and at a significantly higher price. I still believe that the Company has a fundamental value that will in the long-term allow me to realize a healthy capital gain at some future date. I don't like short-term traders or trades. Obviously, I don't respect shorts. My preference is to stick it out until I see something that revises my fundamental analysis. I'll freely sell a loser. I won't dump a stock just because its price fell on bad news from a single quarter or because it has been under attack by shorts, not unless I think that the bad news represents a permanent alteration in the prospects for the business.